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Abstract. Because the prevalence of dengue fever in urban settings in Papua New Guinea is unknown, we investigated
the presence of dengue using the NS1 antigen test in an outpatient-based prospective observational study at Port Moresby
General Hospital. Of 140 patients with acute febrile illnesses, dengue fever was diagnosed in 14.9% (20 of 134; 95%
confidence interval [95% CI] = 9.6–22.4). Malaria (2 of 137; 1.5%; 95% CI = 0.3–5.7), chikungunya (3 of 140; 2.1%; 95%
CI = 0.6–6.6), and bacterial bloodstream infections (0 of 80; 0%; 95% CI = 0–5.7) were uncommon. Dengue fever should
no longer be considered rare in Papua New Guinea.
Globally, an estimated 50–100 million cases of dengue fever
(DF) and hundreds of thousands of dengue hemorrhagic fever
cases occur annually.1 In the Asia Pacific region, dengue is
recognized as an emerging vector-borne disease.2 However,
despite the predominance of dengue virus and vectors in this
region, DF is rarely diagnosed in Papua New Guinea (PNG),
and dengue hemorrhagic fever has not been reported apart
from an unconfirmed outbreak more than a decade ago.3
Nevertheless, this may be a reflection of (1) the lack of viral
diagnostic facilities in PNG, (2) the fact that previous dengue
investigations have been conducted in predominantly rural
populations,3–5 and (3) the low index of clinical suspicion
among health workers in PNG.
Because the prevalence of DF in urban PNG is unknown,
we hypothesized that it may be an important cause of acute
febrile illnesses and conducted a prospective observational
study at Port Moresby General Hospital, the main tertiary hos-
pital in PNG, between February and August of 2013. Patients
were recruited through the Adult’s and Children’s Outpatient
Departments. Children were defined as age £ 14 years. Study
inclusion criteria included (1) an axillary temperature ³ 38°C
or a history of fever in the past 5 days, (2) clinical signs and
symptoms suggestive of an acute febrile illness, and (3) a signed
informed consent by the patient or a guardian. Those who did
not fulfill the inclusion criteria and infants age < 1 month were
excluded. Demographic data, relevant clinical signs, symptoms,
and basic clinical assessments were recorded on standardized
case report forms by a study clinician (V.A.). Ethical approval
was obtained from the University of Papua New Guinea
School of Medicine and Health Sciences Ethics Committee
and the Medical Research Advisory Committee of PNG.
A diagnosis of dengue was based on the serological detection
of NS1 antigens. The Bio-Rad Platellia Dengue NS1 antigen
assay was used, and results were classified as negative, equiv-
ocal, or positive based on a signal ratio of < 0.5, 0.5–1.0, or
> 1.0, respectively. A diagnosis of malaria was based on micro-
scopic examination of thick blood smears. Chikungunya was
investigated by use of an immunoglobulin M (IgM) antibody
immunochromatographic rapid diagnostic test (BIOLINE,
Kyonggido, Korea) with polymerase chain reaction confirma-
tion in positive cases as part of an outbreak investigation.6
Biochemistry parameters were analyzed using a Vitros
250 chemistry analyzer, whereas full blood counts were per-
formed using an automated Sysmex XT1800i hematology
analyzer. Blood (4–5 mL) was collected for culture in
Trypticase Soya Broth media, which cover a wide spectrum of
organisms, that were prepared in house with manual
workup for 72 hours. Statistical analysis was performed using
STATA 11.0 (Stata Corp., College Station, TX). The Mann–
Whitney test was used for comparisons between groups for
continuous variables, and the two-sided Fisher’s exact test was
used for comparisons between proportions.
Of 140 patients with acute febrile illnesses screened, none
refused consent, 57.1% were males, and 38.6% were children.
The median age was 6 (interquartile range = 3–8) years in
children and 33 (interquartile range = 25–39) years in adults.
In six patients, dengue could not be investigated because of
inadequate samples. Of those patients tested, DF was equivocal
and considered a possible diagnosis in 3 patients and positive in
20 patients (20 of 134; 14.9%; 95% CI [95% CI] = 9.6–22.4).
Clinical and laboratory features of these patients combined
are shown in Table 1. Most (73.9%) were urban residents
(residing within the city of Port Moresby), with no particular
suburb showing a greater proportion of DF cases. Vomiting
was significantly more common in children with a positive
NS1 test compared with those with a negative test (66.7%
versus 20.9%; P = 0.012). In adults, chills and rigors (92.3%
versus 58.3%; P = 0.025) and myalgia (100% versus 67.8%;
P = 0.015) were significant clinical features of DF.
Malaria (2 of 137; 1.5%; 95% CI = 0.3–5.7), chikungunya
(3 of 140; 2.1%; 95% CI = 0.6–6.6), and bacterial bloodstream
infections (0 of 80; 0%; 95% CI = 0–5.7) were uncommon. A
pathogen could not be identified in 80.0% (112 of 140; 95%
CI = 72.2–86.1) of patients. Significantly higher rates of throm-
bocytopenia, neutropenia, monocytosis, and eosinopenia were
observed in patients with DF (Table 1). There was evidence of
hemoconcentration in significantly more patients with DF with
hemoglobin levels ³ 15 g/dL (19.1% versus 4.9%; P = 0.045),
resulting in a significant difference in median hemoglobin and
pack cell volume observed between the two groups (Table 1).
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A high proportion of patients with DF had elevated aspartate
aminotransferase (AST; 62.5% versus 36.7%; P = 0.07).
Other laboratory parameters were mostly within normal
PNG limits,7 and observed differences did not seem to have
clinical significance.
Using the NS1 test, this study is the first from an urban
setting in PNG to investigate DF in patients with acute febrile
illnesses. We showed a high prevalence rate of 14.9% com-
pared with 8% in a previous report from the north coast of
PNG that used the NS1 and serology tests in paired samples.4
In addition, malaria, which is often considered endemic in
PNG, contributed only 1.5% of cases, whereas chikungunya
accounted for 2.1% of cases. Findings from this study support
our hypothesis that a lack of viral diagnostic facilities
compounded by the lack of dengue baseline prevalence data
and the low index of clinical suspicion by health workers may
have contributed to an underestimation of the true burden of
DF in PNG. This underestimation continues to place PNG in
a vulnerable position with regards to the risk of potential
outbreaks and the awareness of dengue as an emerging disease.
Although malaria was the most common clinical diagnosis
in patients in our study, these data do not support malaria as
an important cause of acute febrile illnesses in Port Moresby.
Our findings are supported by studies from malaria-endemic
areas that strongly suggest that, with the global decline in
malaria, viral pathogens may become important etiological
causes of acute febrile illnesses.5,8 This has important clinical
implications for PNG, where most patients will not benefit
from empiric use of antibiotics or antimalarial drugs, there-
fore increasing the need for accurate diagnostics.
Our study had limitations. First, we could not exclude bac-
terial causes of acute febrile illnesses in 39% of patients with a
positive NS1 test and 44% of patients with a negative test
(Table 1), and the manual blood culture system used in this
study may not be optimal to detect bacteremia. However, the
fact that the majority of our patients were outpatient cases
and the low incidence of bacterial bloodstream infection that
has been reported, even in severely ill PNG patients, when
automated blood culture systems are used9,10 highly suggest
that bacterial infection was not present. Second, serotyping of
dengue viruses and confirmatory diagnosis using more sensi-
tive molecular methods were not possible. Although the den-
gue NS1 antigen test proved to be a cost-effective diagnostic
tool for our setting that can be used under field conditions,
which was shown in this study as well as in a previous study,4
additional validation studies comparing its use with more
Table 1
Baseline demographic, clinical, and laboratory characteristics of study participants
Dengue NS1 test positive (N = 23) Dengue NS1 test negative (N = 111) P value
Male sex 15/23 (65.2) 61/111 (55.0) 0.49
Children 9/23 (39.1) 43/111 (38.7) > 0.99
Chills and rigors 18/23 (78.3) 58/103 (56.3) 0.06
Vomiting 11/ 23 (47.8) 23/104 (22.1) 0.02
Headache 20/23 (87.0) 70/98 (71.4) 0.18
Flushing of the face 16/23 (69.6) 57/101 (56.4) 0.35
Eye redness 11/23 (47.8) 52/103 (50.5) > 0.99
Rash 2/23 (8.7) 16/100 (16.0) 0.52
Dark urine 0/23 (0.0) 1/103 (1.0) > 0.99
Diarrhea 4/23 (17.4) 15/100 (15.0) 0.75
Enlarged cervical glands 1/23 (4.3) 13/100 (13.0) 0.47
Myalgia 18/23 (78.3) 65/94 (69.1) 0.45
Arthralgia 18/23 (78.3) 71/94 (75.5) > 0.99
Temperature ( °C) 38.3 [38.0–38.6] 38.3 [37.6–39.0] 0.94
Hemoglobin (g/dL) 13.8 [11.9–14.5] 12.2 [11.0–13.4] 0.01
Packed cell volume 40.7 [35.0–44.0] 37.0 [33.5–41.0] 0.02
Mean cell volume 81.0 [76.0–83.0] 78.0 [70.9–83.0] 0.36
Mean cell hemoglobin 28.0 [26.0–31.0] 26.3 [24.0–29.0] 0.06
Mean cell hemoglobin concentration 33.4 [32.0–34.0] 32.2 [31.0–33.7] 0.22
Red blood cells 5.0 [4.8–5.4] 4.8 [4.4–5.4] 0.27
Platelets ( +109/L) 156.0 [73.0–205.0] 212.0 [162.0–268.0] 0.002
Thrombocytopenic (platelets < 100 + 109/L) 7/21 (33.3) 9/101 (8.9) 0.01
Total white blood cells ( +109/L) 5.3 [4.7–9.6] 7.7 [5.7–10.8] 0.06
Neutrophils (%) 52.0 [34.0–71.9] 65.0 [57.0–76.0] 0.02
Lymphocytes (%) 37.0 [15.0–45.0] 23.0 [13.0–33.0] 0.08
Monocytes (%) 13.0 [9.0–16.0] 9.0 [6.0–11.0] 0.002
Eosinophils (%) 0.8 [0.0–1.3] 1.8 [0.4–4.0] 0.008
Urea (mmol/L) 4.9 [3.5–5.7] 3.8 [2.8–5.1] 0.06
Creatinine (mmol/L) 80.0 [44.0–106.5] 67.0 [45.0–93.0] 0.51
Sodium (mmol/L) 137.0 [134.0–140.0] 140.0 [138.0–142.0] 0.01
Potassium (mmol/L) 4.1 [3.7–4.5] 4.0 [3.7–4.3] 0.44
Chloride (mmol/L) 104.0 [102.0–106.0] 106.0 [104–109] 0.04
AST (U/L) 75.0 [36.0–129.5] 42.0 [31.0–66.0] 0.09
Alanine aminotransferase (U/L) 40.0 [28.5–66.0] 37.0 [25.0–55.0] 0.64
Alkaline phosphatase (U/L) 104.5 [75.5–203.5] 111.0 [76.0–213.0] 0.58
Total protein (g/L) 79.5 [72.5–83.0] 77.0 [72.0–81.0] 0.35
Albumin (g/L) 38.0 [34.0–42.0] 40.0 [36.0–43.0] 0.25
Positive blood culture 0/14 (0) 0/66 (0) −
Data are numbers (percentages) or medians [interquartile ranges].
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sensitive diagnostic methods are needed. Third, we were
unable to further identify pathogens in 80% of our patients.
These data suggest that DF should no longer be considered
uncommon in PNG patients with acute febrile illnesses,
particularly in urban areas. Because extravasation is a feature
of both dengue hemorrhagic fever and DF, the presence of
hemoconcentration in some of our patients with DF may also
suggest the possibility of unrecognized dengue hemorrhagic
disease. Additional studies will be needed to investigate this
observation as well as the seasonality of DF in PNG.
Although most patients with acute febrile illnesses may not
benefit from antibiotics and antimalarial drugs, the high rate
of unidentified pathogens further highlights the need for
accurate diagnostics that can guide the rational use of anti-
microbial drugs in PNG.
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